Simergent is developing an affordable home dialysis devices to address unmet patient needs and improve value-based care.
Simergent has raised $7.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2024.
Simergent's investors include i2E, Pathway Bioventures, Oklahoma Seed Capital Fund, SeedStep Angels.
Simergent is headquartered in Chicago, United States.
Simergent is developing an affordable home dialysis devices to address unmet patient needs and improve value-based care.
Simergent is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Simergent — Funding & Investors." VCBacked, May 13, 2024, https://www.vcbacked.co/company/simergent. Accessed September 30, 2026.
VCBacked. (2024). Simergent — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/simergent
{{cite web |title=Simergent — Funding & Investors |url=https://www.vcbacked.co/company/simergent |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated